Arena Pharmaceuticals Inc (ARNA) Return on Equity ROE from the fourth quarter 2021 to fourth quarter 2019 and annually, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arena Pharmaceuticals Inc   (NASDAQ: ARNA)

Arena Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Arena Pharmaceuticals Inc in the fourth quarter 2021?
Arena Pharmaceuticals Inc recorded a cumulative net loss of $-616 million during 12 months ending in the fourth quarter 2021, resulting in a negative return on equity (ROE) of -69.83%.

Within the Major Pharmaceutical Preparations industry 357 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2021 from 0 to 4569.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Equity Change -37.69 % -31.56 % -21.85 % 9.86 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -616 -583 -484 -423 -405
Return On Equity (TTM) -69.83 % -59.21 % -44.96 % -36.95 % -36.12 %
ARNA's Total Ranking # 4569 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 673 801 971 1,086 1,080
Seq. Equity Change -15.92 % -17.54 % -10.58 % 0.51 % -7.65 %
Seq. Net Income Change - - - - -

Back to ARNA Management Effectiveness >> ARNA's 5 Years Annual ROE >> Compare ARNA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 358
Sector # 750
Overall # 4569

Return On Equity Statistics
High Average Low
168.05 %
-32.59 %
-337.22 %
(Dec 31 2013)   (Sep 30 2016)





ARNA Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Equity in Millions 673 1,080 606 207 40
Y / Y Equity Change -37.69 % 78.22 % 192.67 % 412.8 % -24.55 %
Net Income in Millions -616 -405 -29 -93 -23
Y / Y Net Income Change - - - - -
Return On Equity -91.56 % -37.46 % -4.85 % -44.77 % -56.68 %

Back to ARNA Management Effectiveness >> ARNA's 5 Years Annual ROE >> Compare ARNA ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ARNA's' Return on Equity at Yahoo Finance
ARNA's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ARNA's Competitors
Subscribers only: Roe for Arena Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Equity for ARNA's Customers




Companies with similar Return On Equity at Dec 31 2021, within Healthcare Sector ROE

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.